Aura Biosciences Inc.

AURA | NASDAQ

Price Alert Chart Builder DCF Calculator

$6.36

-$0.08 (-1.24%)

At close: Sep 21, 2026, 4:00 PM ET

$6.42

+$0.06 (+0.93%)

Pre-market: Sep 22, 2026, 9:20 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $657.86M

Enterprise Value $350.61M

Beta 0.40

Average Volume 685.4K

Shares Outstanding (Diluted) 94.86M

Shares Change YoY 63.51%

Institutional Ownership 75.44%

Exchange NASDAQ

ISIN US05153U1079

Price Performance

Price Change 1M -19.1%

Price Change 3M -9.4%

Price Change 6M -1.9%

Price Change YTD 20.0%

Price Change 1Y 3.3%

Price Change 3Y -31.2%

Price Change 5Y -57.0%

1M CAGR (ann.) -20.4%

1Y CAGR (ann.) 1.6%

5Y CAGR (ann.) N/A

All-Time CAGR -15.8%

Valuation

PE Ratio -3.57

Forward PE N/A

PEG Ratio -0.37

Forward PEG 0.40

PS Ratio N/A

Forward PS 133.60

PB Ratio 2.09

P/FCF Ratio -6.41

P/Adj. FCF Ratio -5.23

P/OCF Ratio -5.89

EV/Sales N/A

EV/EBIT -2.63

EV/EBITDA -2.66

EV/FCF -3.42

Earnings Yield -28.0%

FCF Yield -15.6%

Adj. FCF Yield -19.1%

Financial Health

Net Cash $323.84M

Total Debt $16.59M

Cash & Short-Term Investments $323.84M

Total Assets $348.13M

Current Ratio 16.82

Quick Ratio 16.82

Debt / Equity Ratio 0.05

Debt / EBITDA -0.13

Debt / FCF -0.16

OCF / Debt -6.17

Interest Coverage 0.00

Altman Z-Score 9.56

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -22.6%

Returns

Return on Assets -37.6%

Return on Equity -73.2%

Return on Invested Capital -41.6%

Return on Capital Employed -42.0%

Return on Tangible Assets -37.6%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 0.3%

EPS CAGR 5Y 2.5%

EPS CAGR 10Y N/A

FCF CAGR 3Y -16.2%

FCF CAGR 5Y -17.8%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 8

EPS Growth Next 3Y 22.5%

Revenue Growth Next 3Y N/A

Earnings Date Nov 11, 2026

EPS Estimate (next Q) -$0.37

EPS Growth Est (next Q) -8.0%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $17.50

Price Target Upside 175.2%

Cash Flow

Operating Cash Flow $-102.31M

Free Cash Flow $-102.65M

Adj. Free Cash Flow $-125.82M

FCF Per Share -$1.08

OCF Per Share -$1.08

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-138.08M

EBITDA $-131.65M

Net Income $-131.01M

EPS (Diluted) -$1.78

Revenue / Employee N/A

Profit / Employee $-1.16M

Employees 113